📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities. (2021)

First Author: Vaughan D

Attributed to: FSTL3: A Crucial Regulator of Sertoli Cell Proliferation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1242/dmm.047555

PubMed Identifier: 33408083

Publication URI: http://europepmc.org/abstract/MED/33408083

Type: Journal Article/Review

Volume: 14

Parent Publication: Disease models & mechanisms

Issue: 2

ISSN: 1754-8403